Subcutaneous Drug Delivery Devices Market Size, Share & Forecast Report - 2026 to 2030

The global subcutaneous drug delivery devices market size is expected to grow at a significant CAGR of around 7.5% during the forecast period 2025 to 2030. The increasing prevalence of chronic diseases is a key factor to drive the market. The growing prevalence of cardiovascular diseases and diabetes and an increase in biological drug development are some other factors to uplift the market. Moreover, technological advancement, a growing geriatric population, and increasing demand for improved subcutaneous drug delivery devices are anticipated to propel the market growth over the forecast period. However, strict regulation for approval and the high cost of the advanced delivery systems are some factors to prevent the market during the forecast period.

Industry Trends Shaping the Subcutaneous Drug Delivery Devices Market

• Smart, Connected Injectors: Devices are increasingly designed with built-in sensors, digital dose tracking, reminders, and Bluetooth or NFC connectivity. These smart injectors sync with mobile apps, improving adherence and enabling remote patient monitoring.
• Rise of Wearable and High-Volume Injectors: Wearable injector systems capable of delivering large-volume biologic drugs over extended periods are rapidly gaining traction. These ergonomically designed systems offer enhanced patient comfort and stability for medications, especially for chronic conditions.
• Needle-Free and Minimally Invasive Technologies: Jet injectors and microneedle platforms are becoming popular alternatives to traditional needles. These needle-free systems reduce pain, needle-phobia, and the risk of needlestick injuries, elevating patient experience.
• Prefilled Syringes and Autoinjectors: Prefilled and preloaded syringes—as well as autoinjectors—are increasingly favored due to their convenience, dose accuracy, and enhanced safety profile. This is especially true in the biologics space where dosing precision is critical.
• Personalized and Patient-Centric Designs: Customizable drug delivery solutions—offering adjustable dosing, tailored injection speed, and improved ergonomics—are on the rise, catering to individual patient needs and enhancing usability for pediatric, geriatric, and motor-impaired users.

Subcutaneous Drug Delivery Devices Market Opportunities:

The global subcutaneous drug delivery devices market is brimming with opportunities as healthcare increasingly moves toward patient-centric, at-home care models. Chronic conditions like diabetes, autoimmune diseases, and oncology treatments are driving demand for self-administered therapies, while technological advancements—including live tracking, reminders, and digital integration with telehealth—are enhancing both adherence and convenience for patients. Moreover, the prevalence of blood-borne infections due to needlestick injuries highlights a rising shift toward safer, needle-free and autoinjector systems—offering better safety for both patients and healthcare providers.

A compelling recent development underlining this opportunity: in early 2025, the U.S. FDA approved Onapgo, a novel subcutaneous drug-device combination for patients with Parkinson’s disease. This product delivers apomorphine continuously beneath the skin, significantly reducing “off” episodes and enabling smoother symptom management without frequent conventional injections. This milestone exemplifies how regulatory support is enabling innovative, continuous subcutaneous delivery platforms—opening pathways for further breakthroughs across neurological, metabolic, and lifestyle chronic care domains.

Subcutaneous Drug Delivery Devices Market Segment Insights:

The global subcutaneous drug delivery devices market is segmented into delivery type, usability, distribution channel, and region. By delivery type, the market is segmented into prefilled syringes, pen injectors, auto-injectors, wearable injectors, and needle-free injectors. The pen injectors segment held the largest market share in 2019 and accounted for over 35% market share in terms of revenue across the globe. The segment growth is attributed to factors such as easy product design, growing product approval, and greater social acceptance. In contrast, the wearable injectors segment is accounted for the fastest-growing segment over the forecast period.

On the basis of the distribution channels, the market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment dominated the market in 2019 and accounted for around 45% share of the global subcutaneous drug delivery devices market share in terms of revenue. The segment growth has contributed the factors such as rising patients awareness, increasing self-administration. In contrast, the online segment is projected to grow at the fastest growth rate during the forecast period due to the developer’s discount for these drug delivery devices.

Global Subcutaneous Drug Delivery Devices Market Segmentation:

By Delivery Type:

• Prefilled Syringes
• Pen Injectors
• Auto-injectors
• Wearable Injectors
• Needle-free Injectors

By Usability:

• Disposable
• Reusable

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Global subcutaneous drug delivery devices market size and forecast were obtained by using “Bottom-up” and “Top-down” approaches. Extensive secondary research was conducted to understand the market insights and trends, followed by primary interviews to further validate the information sourced. The report provides both, qualitative and quantitative analyses of the market, the competitive landscape, and the preferred development strategies of key players which help to formulate competitive market strategies and make informed decisions.

Historical & Forecast Period

• 2020-23 – Historical Year
• 2024 – Base Year
• 2025-2030 – Forecast Period

Geographic Coverage: North America Leads the Subcutaneous Drug Delivery Devices Market

Geographically, the subcutaneous drug delivery devices Market report comprises dedicated sections centering on the regional market revenue and trends. The subcutaneous drug delivery devices market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. North America dominated the market and accounted for 45% of the market share in terms of revenue. the segment growth is attributed to factors such as increasing healthcare infrastructure, the presence of major players and continuously increasing strategic initiatives. The subcutaneous drug delivery devices market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Subcutaneous drug delivery devices Market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2020 – 2027.

Subcutaneous Drug Delivery Devices Market Report Coverage:

• Research Methodology
• Research Scope
• Executive Market Summary: Industry Snapshot
• Industry Outlook
• Critical Success Factors (CSFs) for the Market
• Market Dynamics
• Key Opportunities
• Market Porters Five Force Analysis
• Market Value Chain/Ecosystem Analysis
• Market Attractive Investment Proposition
• Market PESTEL Analysis
• Market Positioning of Key Vendors
• Market Segmentation Outlook
• Regional Outlook
• Company Profiles of Key Vendors

Subcutaneous Drug Delivery Devices Market Competition Assessment:

Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy. Key players operating in the global subcutaneous drug delivery devices market are Gerresheimer AG, Ypsomed AG, Medtronic Plc, Novo Nordisk, and Insulet Corporation.

Key Companies:

• Gerresheimer AG
• Ypsomed AG
• Medtronic Plc
• Novo Nordisk
• Insulet Corporation
• Elcam Medical Group
• Becton, Dickinson and Company
• Unilife Corporation
• West Pharmaceutical Services, Inc.
• PharmaJet

Key Questions Answered by Subcutaneous drug delivery devices Market Report:

• Global subcutaneous drug delivery devices market forecasts from 2020-2027
• Regional subcutaneous drug delivery devices market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
• Country-level forecasts from 2020-2027 covering 15 major countries from aforementioned regions
• Subcutaneous drug delivery devices submarket forecasts from 2020-2027 covering the market by delivery type, by usability, by distribution channel, and geography
• Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to subcutaneous drug delivery devices market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level subcutaneous drug delivery devices markets from 2020-2027
• Competitive Landscape and market positioning of top 10 players operating in the subcutaneous drug delivery devices market